Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer

Clinical trial NCT04348643 · WITHDRAWN

Trial details

NCT number: NCT04348643
Sponsor: Chongqing Precision Biotech Co., Ltd
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor Lung Cancer Colorectal Cancer Liver Cancer Pancreatic Cancer Gastric Cancer Breast Cancer

Start date: 2020-02-20
Primary completion: 2023-12-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.